RANA DAVIS: Open Payments
NPI 1720499403 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 47 payments from 15 companies in 2025. Trend: 2023 $1,556 · 2024 $1,264 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $149 |
| Exact Sciences Corporation | 10 | $148 |
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| PFIZER INC. | 4 | $65 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 2 | $29 |
Products named: Cologuard Collection Kit, QULIPTA, NURTEC ODT, GVOKE HYPOPEN, FARXIGA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
